IngentaConnect Effects of rabeprazole on early symptom relief in gastro-oesophag...

Authors: Archimandritis, Athanasios J.¹; Nikolopoulou, Vassiliki; Kouklakis, Georgios; Paraskevas, Emanouil; Avgerinos, Alexandros; Tsianos, Epaminontas; Triantafillidis, John K.

Source: Current Medical Research and Opinion, Volume 21, Number 4, April 2005 , pp. 603-610(8)

Publisher: Informa Healthcare

Abstract:

Background: In controlled clinical trials, rabeprazole effectively improves symptoms and heals oesophageal erosions in patients with gastro-oesophageal reflux disease (GORD).

Aim: To examine symptom relief during week 1 of rabeprazole therapy, in addition to GORD healing, in a clinical practice setting.

Methods: In this 8-week, prospective, multicentre, postauthorisation surveillance study conducted in Greece, patients with GORD (intent-to-treat: efficacy, 272; safety, 273) were treated with rabeprazole 20mg once daily. The primary efficacy end point was the change from baseline in GORD symptom severity on day 1, 2, 3 and 7 using a 5-point Likert scale (1 = no symptoms; 5 = severe symptoms). Oesophageal healing was also evaluated by comparing the results of endoscopic findings at baseline and after 4 and 8 weeks of treatment.

Results: On day 1 of treatment, rabeprazole relieved GORD symptoms across all grades of oesophagitis, with statistically significant (p = 0.0001) improvement in heartburn, regurgitation, epigastric pain and dysphagia. Oesophageal healing was achieved in 77% of patients at week 4 and in 90% at week 8 and treatment was well tolerated.

Conclusions: In a clinical practice setting, rabeprazole provided rapid relief of GORD symptoms, confirming results seen in controlled clinical trials.

Keywords: EFFICACY; GASTRO-OESOPHAGEAL REFLUX DISEASE; POSTMARKETING SURVEILLANCE STUDY; PROTON PUMP INHIBITOR; RABEPRAZOLE; SAFETY

Document Type: Research article

DOI: 10.1185/030079905X41444

Affiliations: 1: Department of Pathophysiology, Laiko Gen Hospital, University of Athens Medical School, Greece

Your trusted access to this article has expired.

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$51.50 plus tax

Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study